Product Information
BUPRENORPHINE-NALOXONE 12-3 MG SL FILM is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $4.4680 per EA under NDC 50742036530. Its NADAC has been published 147 times since Nov 1, 2023.
FDA first approved this application on Jun 2, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12; 3 mg/1; mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742036530
Classification
Generic
Dosage Form
FILM
Route
BUCCAL; SUBLINGUAL
Effective Date
8/19/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212756FDA Approved
6/2/2022
TE Code
AB
On Market Since
8/29/2023
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE-NALOXONE 12-3 MG SL FILM has been published 147 times since Nov 1, 2023, and over the history we have for it it has declined 25.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4680 per EA |
|---|---|
| All-time high | $7.9464 (Dec 13, 2023) |
| All-time low | $3.8234 (Apr 17, 2024) |
| 52-week high | $4.4680 |
| 52-week low | $4.1480 |
| Median price | $4.4105 |
| Average price | $4.8997 |
| Largest weekly change | +62.0% (Aug 21, 2024) |
| Weeks tracked | 147 |
| Tracking since | Nov 1, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the buprenorphine and naloxone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPRENORPHINE-NALOXONE 12-3 MG SL FILM?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE-NALOXONE 12-3 MG SL FILM, manufactured by Ingenus Pharmaceuticals LLC, is $4.4680 per EA (NDC 50742036530), effective Aug 19, 2026.
How has the price of BUPRENORPHINE-NALOXONE 12-3 MG SL FILM changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE-NALOXONE 12-3 MG SL FILM has declined 25.1%. It has been tracked across 147 weekly CMS publications since Nov 1, 2023.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE-NALOXONE 12-3 MG SL FILM?
Since Nov 1, 2023, the NADAC for BUPRENORPHINE-NALOXONE 12-3 MG SL FILM has ranged from a low of $3.8234 (Apr 17, 2024) to a high of $7.9464 (Dec 13, 2023), with a median of $4.4105 per EA.
Are there cheaper alternatives to BUPRENORPHINE-NALOXONE 12-3 MG SL FILM?
No other NADAC-published product currently shares the active ingredient and strength of BUPRENORPHINE-NALOXONE 12-3 MG SL FILM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BUPRENORPHINE-NALOXONE 12-3 MG SL FILM?
BUPRENORPHINE-NALOXONE 12-3 MG SL FILM (NDC 50742036530) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.